type here...

CATEGORIES

Press Release

LATEST

1...101112Page 12 of 12

TRENDING

EDITORS CHOICE

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

Perrigo Voluntarily Recalls Albuterol Sulfate Inhalation Aerosol

Medika Life -
A voluntary U.S. nationwide recall of albuterol sulfate inhalation aerosol to the retail level after previously halting production and distribution.

Survey Finds Widespread Confusion Around US Health Insurance

Medika Life -
Many Americans are confused about the basics of health insurance, despite widespread attention on health care during this year's global pandemic and election season.

Wadhwani Foundation $1 Million In Grants for Covid Families in India

Medika Life -
Wadhwani Foundation Announces $1 Million In Grants To Immediately Help Indian Families Impacted By Covid-19. Donations to 10 charities and organizations will provide medical and financial assistance to patients and families to help reduce the devastating impact and slow COVID-19 spread.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories